Health · 27 views
New indicator for response to therapy in pediatric cancers identified
A study by researchers at the University of Birmingham has identified a new biomarker for response to a specific cancer therapy, treating children with Ewing Sarcoma and other tumor types.
Summary
A study by researchers at the University of Birmingham has identified a new biomarker for response to a specific cancer therapy, treating children with Ewing Sarcoma and other tumor types. The study, which is a Phase I/II treatment arm within the eSMART Trial, was carried out at the Cancer Research UK Clinical Trials Unit (CRCTU), recruited 70 patients, and of those 66 were treated across four countries (the UK, France, the Netherlands and Spain).
AI summaries can be wrong sometimes—always verify important details using the source article.
How AI & Automation are usedMore from Health
Continue reading recent Health coverage
- Aging oxidation drives brain proteins into harmful condensates, study findsContinue reading
- New analysis points to low overdiagnosis in breast cancer screeningContinue reading
- Pennsylvania says an unvaccinated woman has died from measles-related complicationsContinue reading
- Researchers hope powerful new microscope will reveal ‘root cause’ of incurable bowel diseaseContinue reading
Support HappeningNow
Independent AI-powered news analysis is reader-supported. Your contribution helps cover infrastructure, summaries, and continued platform development.
Support HappeningNow